Fidelity Disruptive Medicine ETF (FMED)
NASDAQ (NGS) NASDAQ (NGS) Primary Summary
FMED Chart
2 ETFs That Capitalize on the “Silver Tsunami”
An aging population is leading to a profound demographic shift known as the “Silver Tsunami.” With more Baby Boomers reaching retirement age, the demand for senior living facilities and medicinal innovation is increasing.
AI Opens The Door to This Active Healthcare ETF
Like many sectors, the healthcare industry is poised for disruption from artificial intelligence (AI) technology, which may create an investment opportunity for the Fidelity Disruptive Medicine ETF (FMED). Marred by regulatory scrutiny and rising costs, the healthcare sector overall has had its fair share of challenges in 2025.
First Look At FMED: Poor Performance Merits A Strong Sell Rating
Fidelity Disruptive Medicine ETF invests in innovative healthcare companies, focusing on sectors like robotic surgery, genomics, and advanced diagnostics, aiming to disrupt traditional medical practices. The ETF employs a bottom-up stock picking approach, benchmarking against the MSCI ACWI Index and MSCI All Country World Healthcare Equal Weighted Index. Based on the results so far, this strategy has been a dud, earning this ETF another Strong Sell rating for this series of ETFs.
Fidelity Disruptive Medicine ETF Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| AAL Avraham A. Levitan Glass Jacobson Investment Advisors LLC | 1,260 | $32,241.25 | $36,741.6 | $4,500.35 | 13.96% |
| CY Cathy Yasui Central Pacific Bank - Trust Division | 97 | $2,453 | $2,790.2 | $337.2 | 13.75% |
 Camaron Barta BXM Wealth LLC | 8,690 | $235,064.98 | $250,967.2 | $15,902.22 | 6.77% |
Fidelity Disruptive Medicine ETF (FMED) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Fidelity Disruptive Medicine ETF ever had a stock split?
Fidelity Disruptive Medicine ETF Profile
| NASDAQ (NGS) Exchange | US Country |
Overview
This company operates a fund focused on investing in disruptive medicine companies that challenge traditional healthcare systems through innovative solutions. The core investment strategy hinges on allocating at least 80% of its assets into securities of companies that are at the forefront of medical innovation. These entities either have in place or are in the process of developing non-conventional methods that aim to revolutionize the delivery of healthcare products and services. Fidelity's disruptive strategies are instrumental in identifying these pioneering developments, seeking out companies that have the potential to significantly alter and enhance current market practices, potentially displacing existing companies over time. The fund's portfolio is non-diversified, indicating a concentrated investment approach in the disruptive medicine sector.
Products and Services
- Investment in Disruptive Medicine Securities
- Fidelity's Disruptive Strategies
This service involves the allocation of the fund’s assets towards companies involved in groundbreaking healthcare innovations. By putting at least 80% of its investments into the securities of such entities, the fund aims to support and capitalize on the advancements these companies bring to the medicine and healthcare industry. The focus on disruptive medicine companies that are developing or have developed new approaches highlights the fund’s commitment to transformative healthcare solutions.
Utilizing Fidelity's expertise in identifying companies with innovative solutions, the fund taps into disruptive strategies that aim to invest in companies poised for significant growth. These strategies specifically target firms that are not only pioneering new products and services in healthcare but are also capable of disrupting existing markets and displacing incumbent players over time. This approach allows investors in the fund to potentially benefit from the accelerated growth and market transformation driven by these disruptive companies.
